High-quality HER-2 testing: setting a standard for oncologic biomarker assessment

JAMA. 2004 Apr 28;291(16):2019-20. doi: 10.1001/jama.291.16.2019.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Breast Neoplasms / genetics*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Genes, erbB-2*
  • Genetic Testing / methods
  • Genetic Testing / standards
  • Humans
  • Immunohistochemistry* / standards
  • In Situ Hybridization, Fluorescence* / standards
  • Quality Control
  • Receptor, ErbB-2 / metabolism*

Substances

  • Receptor, ErbB-2